Track: Healthcare

This session explores how the future of space will be advanced with Orbital Reef, a commercially developed, owned, and operated space station to be built in low Earth orbit. Led by principal partners Blue Origin and Sierra Space, Orbital Reef will open the next chapter of human space exploration and development by facilitating the growth of a vibrant ecosystem and business model for the future. Designed to open multiple new markets in space, Orbital Reef will provide anyone with the opportunity to establish their own address in orbit. See how this unique destination will offer research, industrial, international, and commercial customers the cost-competitive end-to-end services they need including space transportation and logistics, space habitation, equipment accommodation, onboard crew support, and ground operations.

Leveraging AI can help healthcare organizations take a patient-centered approach to technological implementations, empowering clinicians with patient information as quickly as possible to find abnormalities faster and contact patients sooner for follow-up appointments that can save lives. Learn how Atlantic Health System’s technology implementation framework resulted in the successful integration of over a dozen artificial intelligence solutions to work in concert with our existing imaging review tools and how these implementations optimize the patient-doctor connection.

We will show how new digital technologies are acting a as a game changer in the way to deliver and improve healthcare. Firstly, the vision of private entities and their collaboration with hospitals to improve their operational efficiency and facilitate the digitalization of the care process. (Home hospitalization, Remote patient monitoring). Also, how open innovation through European funded projects enables the collaboration of stakeholders to work together in testing new technologies at multisite level to improve chronic disease management by using IoT, AI and Big Data (Parkinson, Diabetes)

Axomem has been working with a large 2,000-bed hospital since mid-2020 to create a 4D digital twin combining location and time-based patient and disease data, including COVID19 and MDROs (superbugs). This has allowed infectious disease team members to see, understand and predict disease transmission in a much more granular and intuitive manner than ever before. Mr Whiteley will present on how the project established a multi-disciplinary team of clinicians, specialists, administrators and IT experts, along with the successes and unique lessons learnt from the journey to date.

Learn how to build and utilize a digital twin of human knee and how to utilize it for: 1) Diagnosis of injuries of knee and acceleration of rehabilitation outcomes 2) Treating Chronic conditions like arthritis 3) Improving health and wellness 4) Enhance performance for sports and athletics activities Learn how to measure sensor information relevant for the digital twin of the human knee. Learn about the benefits of this paradigm from the perspective of the patient, sports physician and the medical facilities like hospital.

This session will explore LPWAN technology, why is it needed, and what use cases this technology opens door to. What benefit does LPWAN technology offer for PET trackers? How does MSD’s pet tracker provide services that go beyond location tracking, and what is the business outcome?

Clinical trials are the way in which pharmaceutical companies ensure patients safety and measure the effectiveness of the treatment. In the last three years there has been a rise in decentralized clinical trials (DET). In this presentation the clinical artificial intelligence company Legit.Health reveals the work they have done along side the pharmaceutical company Almirall. By using computer vision during clinical trials they have uncovered a window into the future of clinical trials, with higher probability and lower costs.

This March, 16 EU countries, including Spain, committed to the deployment of the IPCEI (Important Project of Common European Interest) on Health. It will support the funding gap for innovative projects that address market failures within the EU to achieve a strong healthcare industry. In this session, our panel of experts will provide a first approach to the opportunities that healthcare technology, medical devices and digital health present to drive the reindustrialisation of Europe, the potential of Spain in this area and the market gaps that need to be jointly addressed.

Smart manufacturing is revolutionizing the way the industrial world works. From robotics, to automation, to data analysis, manufacturers can dramatically improve their processes and gain a competitive edge. By connecting industrial assets, processes, people, and analytics, manufacturers can capture real-time data from their production chain and use this data to optimize their operations and make better decisions on how to allocate resources for maximum efficiency. Michelangelo will discuss Merck’s vision and roadmap from ManuFacturing to SmartFacturing.

In medicine, the concept of digital twin is used to describe the use of individual-specific computer models for the prevention, prediction, diagnosis and treatment of a disease, as well as the optimization and personalization of intervention options. It provides a patient-specific means to answer therapeutic questions, from the discovery of new therapies to the prediction of the effect of a proposed therapeutic intervention and optimization of care. This session will explore how digital twins can improve healthcare and the main hurdles to their development and acceptance. Learn how digital twins can directly benefit patients by allowing for personalized treatment.